Prevalence of Antimicrobial Resistant of Vibrio parahaemolyticus Isolated from Diarrheal Patients — Six PLADs, China, 2016−2020

WHAT IS ALREADY KNOWN ON THIS TOPIC? Vibrio parahaemolyticus (V. parahaemolyticus) is frequently resistant to common antimicrobials such as ampicillin and generally highly susceptible to most clinically used antimicrobials. WHAT IS ADDED BY THIS REPORT? V. parahaemolyticus were highly resistant to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Haihong, Pires, Sara M., Ellis-Iversen, Johanne, Tang, Zhen, Zhang, Xiaoai, Liu, Jikai, Li, Weiwei, Cui, Qingpo, Zou, Jing, Fu, Ping, Guo, Yunchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2021
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393055/
https://www.ncbi.nlm.nih.gov/pubmed/34594947
http://dx.doi.org/10.46234/ccdcw2021.135
Descripción
Sumario:WHAT IS ALREADY KNOWN ON THIS TOPIC? Vibrio parahaemolyticus (V. parahaemolyticus) is frequently resistant to common antimicrobials such as ampicillin and generally highly susceptible to most clinically used antimicrobials. WHAT IS ADDED BY THIS REPORT? V. parahaemolyticus were highly resistant to cefazolin and ampicillin: 94.4% and 37.0%, respectively. However, it was below 3% resistance to all 10 other antimicrobials including clinically relevant agents and even imipenem. The overall levels of antimicrobial resistance and multidrug resistance were 95.1% and 3.3%, respectively. The distribution of antimicrobial resistance and the multidrug resistance had regional, temporal, sexual, and isolated source strain variation. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? This study provides data on drug resistance of V. parahaemolyticus in Chinese clinical settings, which will help develop a public health strategy.

Ejemplares similares